Absorption & Elimination of Radiolabelled GSK2269557

NCT03315559 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: [14C]-GSK2269557 IV infusion
DRUG: GSK2269557 via DPI
DRUG: [14C]-GSK2269557 oral solution

Sponsor

GlaxoSmithKline